Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Genetic identity and biological phenotype of a transmitted/founder virus representative of nonpathogenic simian immunodeficiency virus infection in African green monkeys.

Gnanadurai CW, Pandrea I, Parrish NF, Kraus MH, Learn GH, Salazar MG, Sauermann U, Töpfer K, Gautam R, Münch J, Stahl-Hennig C, Apetrei C, Hahn BH, Kirchhoff F.

J Virol. 2010 Dec;84(23):12245-54. doi: 10.1128/JVI.01603-10. Epub 2010 Sep 29.

2.

A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays.

Kraus MH, Parrish NF, Shaw KS, Decker JM, Keele BF, Salazar-Gonzalez JF, Grayson T, McPherson DT, Ping LH, Anderson JA, Swanstrom R, Williamson C, Shaw GM, Hahn BH.

Virology. 2010 Feb 20;397(2):346-57. doi: 10.1016/j.virol.2009.11.019. Epub 2009 Dec 8.

3.

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, Decker JM, Wang S, Baalwa J, Kraus MH, Parrish NF, Shaw KS, Guffey MB, Bar KJ, Davis KL, Ochsenbauer-Jambor C, Kappes JC, Saag MS, Cohen MS, Mulenga J, Derdeyn CA, Allen S, Hunter E, Markowitz M, Hraber P, Perelson AS, Bhattacharya T, Haynes BF, Korber BT, Hahn BH, Shaw GM.

J Exp Med. 2009 Jun 8;206(6):1273-89. doi: 10.1084/jem.20090378. Epub 2009 Jun 1.

4.

Origin and biology of simian immunodeficiency virus in wild-living western gorillas.

Takehisa J, Kraus MH, Ayouba A, Bailes E, Van Heuverswyn F, Decker JM, Li Y, Rudicell RS, Learn GH, Neel C, Ngole EM, Shaw GM, Peeters M, Sharp PM, Hahn BH.

J Virol. 2009 Feb;83(4):1635-48. doi: 10.1128/JVI.02311-08. Epub 2008 Dec 10.

5.

Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity.

Cobbs CS, Soroceanu L, Denham S, Zhang W, Kraus MH.

Cancer Res. 2008 Feb 1;68(3):724-30. doi: 10.1158/0008-5472.CAN-07-2291.

6.

Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon.

Van Heuverswyn F, Li Y, Bailes E, Neel C, Lafay B, Keele BF, Shaw KS, Takehisa J, Kraus MH, Loul S, Butel C, Liegeois F, Yangda B, Sharp PM, Mpoudi-Ngole E, Delaporte E, Hahn BH, Peeters M.

Virology. 2007 Nov 10;368(1):155-71. Epub 2007 Jul 24.

7.

Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness.

Cobbs CS, Soroceanu L, Denham S, Zhang W, Britt WJ, Pieper R, Kraus MH.

J Neurooncol. 2007 Dec;85(3):271-80. Epub 2007 Jun 23.

PMID:
17589804
8.

Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees.

Takehisa J, Kraus MH, Decker JM, Li Y, Keele BF, Bibollet-Ruche F, Zammit KP, Weng Z, Santiago ML, Kamenya S, Wilson ML, Pusey AE, Bailes E, Sharp PM, Shaw GM, Hahn BH.

J Virol. 2007 Jul;81(14):7463-75. Epub 2007 May 9.

9.

Downregulation of Sef, an inhibitor of receptor tyrosine kinase signaling, is common to a variety of human carcinomas.

Zisman-Rozen S, Fink D, Ben-Izhak O, Fuchs Y, Brodski A, Kraus MH, Bejar J, Ron D.

Oncogene. 2007 Sep 6;26(41):6093-8. Epub 2007 Apr 9.

PMID:
17420726
10.

Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors.

Masuelli L, Focaccetti C, Cereda V, Lista F, Vitolo D, Trono P, Gallo P, Amici A, Monaci P, Mattei M, Modesti M, Forni G, Kraus MH, Muraro R, Modesti A, Bei R.

Int J Oncol. 2007 Feb;30(2):381-92.

PMID:
17203220
11.

Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation.

Li X, Deng W, Nail CD, Bailey SK, Kraus MH, Ruppert JM, Lobo-Ruppert SM.

Oncogene. 2006 Jan 26;25(4):609-21.

12.

Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells.

Arnoletti JP, Buchsbaum DJ, Huang ZQ, Hawkins AE, Khazaeli MB, Kraus MH, Vickers SM.

J Gastrointest Surg. 2004 Dec;8(8):960-9; discussion 969-70.

PMID:
15585383
13.

Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients.

Bei R, Budillon A, Masuelli L, Cereda V, Vitolo D, Di Gennaro E, Ripavecchia V, Palumbo C, Ionna F, Losito S, Modesti A, Kraus MH, Muraro R.

J Pathol. 2004 Nov;204(3):317-25.

PMID:
15476268
14.

Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma.

Bei R, Pompa G, Vitolo D, Moriconi E, Ciocci L, Quaranta M, Frati L, Kraus MH, Muraro R.

J Pathol. 2001 Oct;195(3):343-8.

PMID:
11673832
15.

ErbB2 immune response in breast cancer patients with soluble receptor ectodomain.

Visco V, Bei R, Moriconi E, Gianni W, Kraus MH, Muraro R.

Am J Pathol. 2000 Apr;156(4):1417-24.

16.

Profile of genetic alterations and tumorigenicity of human breast cancer cells.

Zimonjic DB, Keck-Waggoner CL, Yuan BZ, Kraus MH, Popescu NC.

Int J Oncol. 2000 Feb;16(2):221-30.

PMID:
10639563
17.

Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling.

Fedi P, Bafico A, Nieto Soria A, Burgess WH, Miki T, Bottaro DP, Kraus MH, Aaronson SA.

J Biol Chem. 1999 Jul 2;274(27):19465-72.

18.

Immune responses to all ErbB family receptors detectable in serum of cancer patients.

Bei R, Masuelli L, Moriconi E, Visco V, Moretti A, Kraus MH, Muraro R.

Oncogene. 1999 Feb 11;18(6):1267-75.

19.

Molecular heterogeneity of RET loss of function in Hirschsprung's disease.

Carlomagno F, De Vita G, Berlingieri MT, de Franciscis V, Melillo RM, Colantuoni V, Kraus MH, Di Fiore PP, Fusco A, Santoro M.

EMBO J. 1996 Jun 3;15(11):2717-25.

20.

All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired.

Baulida J, Kraus MH, Alimandi M, Di Fiore PP, Carpenter G.

J Biol Chem. 1996 Mar 1;271(9):5251-7.

21.

Structural organization and expression of the mouse gene encoding alpha-galactosidase A.

Ohshima T, Murray GJ, Nagle JW, Quirk JM, Kraus MH, Barton NW, Brady RO, Kulkarni AB.

Gene. 1995 Dec 12;166(2):277-80.

PMID:
8543175
22.

Characterization of a Stat-like DNA binding activity in Drosophila melanogaster.

Sweitzer SM, Calvo S, Kraus MH, Finbloom DS, Larner AC.

J Biol Chem. 1995 Jul 14;270(28):16510-3.

23.

Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.

Alimandi M, Romano A, Curia MC, Muraro R, Fedi P, Aaronson SA, Di Fiore PP, Kraus MH.

Oncogene. 1995 May 4;10(9):1813-21.

PMID:
7538656
24.

Localization of the human HER4/erbB-4 gene to chromosome 2.

Zimonjic DB, Alimandi M, Miki T, Popescu NC, Kraus MH.

Oncogene. 1995 Mar 16;10(6):1235-7.

PMID:
7700649
25.

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B.

Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH, et al.

Science. 1995 Jan 20;267(5196):381-3.

PMID:
7824936
26.

Evolutionary conservation of the EPS8 gene and its mapping to human chromosome 12q23-q24.

Wong WT, Carlomagno F, Druck T, Barletta C, Croce CM, Huebner K, Kraus MH, Di Fiore PP.

Oncogene. 1994 Oct;9(10):3057-61.

PMID:
8084614
27.

The human eps15 gene, encoding a tyrosine kinase substrate, is conserved in evolution and maps to 1p31-p32.

Wong WT, Kraus MH, Carlomagno F, Zelano A, Druck T, Croce CM, Huebner K, Di Fiore PP.

Oncogene. 1994 Jun;9(6):1591-7.

PMID:
8183552
29.

Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells.

Kraus MH, Fedi P, Starks V, Muraro R, Aaronson SA.

Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2900-4.

30.
31.

Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia.

Di Fiore PP, Kraus MH.

Cancer Treat Res. 1992;61:139-60. Review. No abstract available.

PMID:
1360229
32.

Oncogenic potential of erbB-2 in human mammary epithelial cells.

Pierce JH, Arnstein P, DiMarco E, Artrip J, Kraus MH, Lonardo F, Di Fiore PP, Aaronson SA.

Oncogene. 1991 Jul;6(7):1189-94.

PMID:
1713661
33.

Detection and isolation of novel protein-tyrosine kinase genes employing reduced stringency hybridization.

Kraus MH, Aaronson SA.

Methods Enzymol. 1991;200:546-56. No abstract available.

PMID:
1835515
34.

Growth factor-regulated pathways in epithelial cell proliferation.

Aaronson SA, Rubin JS, Finch PW, Wong J, Marchese C, Falco J, Taylor WG, Kraus MH.

Am Rev Respir Dis. 1990 Dec;142(6 Pt 2):S7-10. Review.

PMID:
2252277
35.

Increased erbB-2 gene copies and expression in multiple stages of breast cancer.

Iglehart JD, Kraus MH, Langton BC, Huper G, Kerns BJ, Marks JR.

Cancer Res. 1990 Oct 15;50(20):6701-7.

36.

Implications of erbB-2 overexpression for basic science and clinical medicine.

King CR, Kraus MH, DiFiore PP, Paik S, Kasprzyk PG.

Semin Cancer Biol. 1990 Oct;1(5):329-37. Review.

PMID:
2103506
37.
38.

Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.

Park JB, Rhim JS, Park SC, Kimm SW, Kraus MH.

Cancer Res. 1989 Dec 1;49(23):6605-9.

39.

Autocrine interaction between TGF alpha and the EGF-receptor: quantitative requirements for induction of the malignant phenotype.

Di Marco E, Pierce JH, Fleming TP, Kraus MH, Molloy CJ, Aaronson SA, Di Fiore PP.

Oncogene. 1989 Jul;4(7):831-8.

PMID:
2755700
40.
42.

Activated H-ras oncogenes in human kidney tumors.

Fujita J, Kraus MH, Onoue H, Srivastava SK, Ebi Y, Kitamura Y, Rhim JS.

Cancer Res. 1988 Sep 15;48(18):5251-5.

43.

12th codon mutation resulting in c-N-ras activation in acute myelogenous leukemia.

Needleman SW, Devine SE, Kraus MH.

Leukemia. 1988 Feb;2(2):91-3.

PMID:
3278172
44.

Mechanisms by which genes encoding growth factors and growth factor receptors contribute to malignant transformation.

Kraus MH, Pierce JH, Fleming TP, Robbins KC, Di Fiore PP, Aaronson SA.

Ann N Y Acad Sci. 1988;551:320-35; discussion 336. Review. No abstract available.

PMID:
3072902
45.

Different mechanisms are responsible for oncogene activation in human mammary neoplasia.

Kraus MH, Di Fiore PP, Pierce JH, Aaronson SA.

Cancer Treat Res. 1988;40:49-66. Review. No abstract available.

PMID:
2908661
46.

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells.

Di Fiore PP, Pierce JH, Kraus MH, Segatto O, King CR, Aaronson SA.

Science. 1987 Jul 10;237(4811):178-82.

PMID:
2885917
47.

Human HER2 (neu) promoter: evidence for multiple mechanisms for transcriptional initiation.

Tal M, King CR, Kraus MH, Ullrich A, Schlessinger J, Givol D.

Mol Cell Biol. 1987 Jul;7(7):2597-601.

49.

A novel human gene closely related to the abl proto-oncogene.

Kruh GD, King CR, Kraus MH, Popescu NC, Amsbaugh SC, McBride WO, Aaronson SA.

Science. 1986 Dec 19;234(4783):1545-8.

PMID:
3787260
50.

Mammalian cell transformation by a murine retrovirus vector containing the avian erythroblastosis virus erbB gene.

Gazit A, Pierce JH, Kraus MH, Di Fiore PP, Pennington CY, Aaronson SA.

J Virol. 1986 Oct;60(1):19-28.

Supplemental Content

Loading ...
Support Center